Holen Sie sich die Stockscreener-App
1.70
1.73%
-0.03
Handel nachbörslich:
1.70
Essa Pharma Inc Aktie (EPIX) Neueste Nachrichten
14,525 Shares in ESSA Pharma Inc. (NASDAQ:EPIX) Bought by Squarepoint Ops LLC - Defense World
211,204 Shares in ESSA Pharma Inc. (NASDAQ:EPIX) Acquired by Two Sigma Investments LP - Defense World
Jane Street Group LLC Acquires Shares of 45,810 ESSA Pharma Inc. (NASDAQ:EPIX) - Defense World
82,600 Shares in ESSA Pharma Inc. (NASDAQ:EPIX) Purchased by Two Sigma Advisers LP - Defense World
Bank of America Corp DE Buys 812,302 Shares of ESSA Pharma Inc. (NASDAQ:EPIX) - Defense World
BNP Paribas Financial Markets Raises Stock Holdings in ESSA Pharma Inc. (NASDAQ:EPIX) - Defense World
ESSA Pharma Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationEPIX - ACCESS Newswire
Cubist Systematic Strategies LLC Buys Shares of 26,287 ESSA Pharma Inc. (NASDAQ:EPIX) - Defense World
ESSA Pharma Inc. Explores Strategic Alternatives After Clinical Trial Termination - TipRanks
ESSA Pharma: Fiscal Q2 Earnings Snapshot - CT Insider
ESSA Pharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2025 - marketscreener.com
ESSA Pharma Reports Q2 2025 Financial Results and Strategic Review - TipRanks
ESSA Pharma Reports Financial Results for Fiscal Second Quarter Ended March 31, 2025 | EPIX Stock News - GuruFocus
ESSA Pharma Reports Financial Results for Fiscal Second Quarter Ended March 31, 2025 - Stock Titan
Press Release Distribution & PR Platform - ACCESS Newswire
ESSA Pharma Inc. (EPIX) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates - ACCESS Newswire
A Look At Essa Pharma Inc (EPIX) Stock Performance - Stocksregister
Investors who hold shares of ESSA Pharma Inc. (NASDAQ: EPIX) Long - openPR.com
Alis Biosciences Launches To Free Cash From Stalled-Out Biotechs - insights.citeline.com
Finance Watch: Investors Push ESSA Pharma, Elevation Oncology To Wind Down - insights.citeline.com
Investor pressures struggling Essa to liquidate, give cash to shareholders - Fierce Biotech
ESSA Pharma Inc. (NASDAQ:EPIX): Are Analysts Optimistic? - simplywall.st
EPIX ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your ESSA Pharma Inc. investment - ACCESS Newswire
We're Not Very Worried About ESSA Pharma's (NASDAQ:EPIX) Cash Burn Rate - Yahoo Finance
EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit with the Schall Law Firm - Eastern Progress
The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025EPIX - PR Newswire
ESSA Pharma Inc. Class Action: Levi & Korsinsky Reminds ESSA Pha - GuruFocus
ESSA Pharma Inc. Class Action: Levi & Korsinsky Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025EPIX - PR Newswire
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - Markets Insider
EPIX Deadline Today: Rosen Law Firm Urges ESSA Pharma Inc. (NASDAQ: EPIX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire
ESSA Pharma Inc. Investors: Please contact the Portnoy Law - GlobeNewswire
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - Business Wire
The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pen - GuruFocus
ESSA Pharma Inc. Securities Fraud Class Action Lawsuit - GlobeNewswire
EPIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Shareholders that lost money on ESSA Pharma Inc.(EPIX) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
EPIX IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, - GlobeNewswire
EPIX IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important March 25 Deadline in Securities Class ActionEPIX - TradingView
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - GlobeNewswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - GlobeNewswire Inc.
ESSA Pharma Inc. Faces Securities Fraud Class Action Over Alleged Investor Misleading Statements - Apna Kal
Investors in ESSA Pharma Inc. Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your RightsEPIX - ACCESS Newswire
Faruqi & Faruqi Reminds ESSA Pharma Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025EPIX - Longview News-Journal
ESSA Pharma Inc. (NASDAQ: EPIX) Investor Alert: Deadline in Lawsuit on March 25, 2025 - openPR
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against ESSA, Cardlytics, Novo Nordisk, and Crocs and Encourages Investors to Contact the Firm - TradingView
EPIX DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 25 Deadline in Securities Class ActionEPIX - TradingView
The Gross Law Firm Reminds ESSA Pharma Inc. Investors of - GlobeNewswire
The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 – EPIX - TradingView
EPIX Lawsuit Alert! Class Action Lawsuit Against ESSA Pharma, Inc. - TipRanks
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):